Show simple item record

dc.contributor.authorErgin Kızılçay, Gamze
dc.contributor.authorToker, Sıdıka
dc.date.accessioned2021-03-02T17:35:28Z
dc.date.available2021-03-02T17:35:28Z
dc.date.issued2020
dc.identifier.citationErgin Kızılçay G., Toker S., "Spectrophotometric determinations of most commonly used statins in pharmaceutical preparations with 2,3-dichloro-5,6-dicyanobenzoquinone", İstanbul Journal of Pharmacy, cilt.50, sa.2, ss.95-102, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_5ed06694-bf17-4814-bf40-6e3dfba0ac48
dc.identifier.urihttp://hdl.handle.net/20.500.12627/4044
dc.identifier.urihttps://dergipark.org.tr/tr/download/article-file/1259669
dc.description.abstractBackground and Aims: In this study, simple, accurate and precise spectrophotometric methods were developed for the determination of five 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitors in pure and pharmaceutical dosage forms. Methods: In the developed methods, atorvastatin fluvastatin, pitavastatin, rosuvastatin and simvastatin were used in this class of drugs called statins. The methods were based on the charge-transfer reaction of n-electron donor drugs with π-acceptor 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). All variables such as temperature, time, reaction medium, amount of reagent were examined for optimal formation of complexes to be given by the drugs with DDQ and optimal conditions were determined. Results: The linearity ranges for atorvastatin, fluvastatin, pitavastatin, rosuvastatin and simvastatin were found to be 0.5-50, 1-6, 2.5-50, 5-25 and 5-50 μg/mL, respectively. Conclusion: The proposed methods were successfully applied to both the pure and the pharmaceutical dosage forms
dc.language.isoeng
dc.subjectAnalitik Kimya
dc.subjectSağlık Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectEczacılık
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectKlinik Tıp (MED)
dc.titleSpectrophotometric determinations of most commonly used statins in pharmaceutical preparations with 2,3-dichloro-5,6-dicyanobenzoquinone
dc.typeMakale
dc.relation.journalİstanbul Journal of Pharmacy
dc.contributor.departmentİstanbul Üniversitesi , Eczacılık Fakültesi , Analitik Kimya
dc.identifier.volume50
dc.identifier.issue2
dc.identifier.startpage95
dc.identifier.endpage102
dc.contributor.firstauthorID2214156


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record